Thyroid C-cell Tumors: In rodent scientific studies, semaglutide has been shown to trigger thyroid C-cell tumors. It can be unfamiliar no matter if this chance applies to humans, but semaglutide is contraindicated in patients with a private or relatives record of medullary thyroid carcinoma (MTC) or individuals with A number of Endocrine Neoplasia